CME Group (CME) Upgraded at Goldman Sachs Group

CME Group (NASDAQ:CME) was upgraded by analysts at Goldman Sachs Group from a “neutral” rating to a “buy” rating in a report issued on Wednesday, The Fly reports.

A number of other brokerages also recently commented on CME. Barclays boosted their target price on shares of CME Group from $139.00 to $149.00 and gave the stock an “overweight” rating in a report on Tuesday, October 10th. Bank of America upped their price objective on shares of CME Group from $173.00 to $175.00 and gave the company a “buy” rating in a report on Friday, February 2nd. Zacks Investment Research upgraded shares of CME Group from a “hold” rating to a “buy” rating and set a $164.00 price objective on the stock in a report on Tuesday, January 2nd. BidaskClub downgraded shares of CME Group from a “strong-buy” rating to a “buy” rating in a report on Wednesday, October 18th. Finally, Sandler O’Neill restated a “buy” rating and set a $175.00 price objective on shares of CME Group in a report on Friday, February 2nd. Three equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. CME Group presently has a consensus rating of “Buy” and a consensus target price of $155.08.

Shares of CME Group (NASDAQ CME) opened at $157.65 on Wednesday. CME Group has a one year low of $114.82 and a one year high of $163.00. The firm has a market cap of $52,210.14, a PE ratio of 13.20, a P/E/G ratio of 2.01 and a beta of 0.64. The company has a quick ratio of 1.05, a current ratio of 1.03 and a debt-to-equity ratio of 0.10.

CME Group (NASDAQ:CME) last announced its earnings results on Thursday, February 1st. The financial services provider reported $1.12 EPS for the quarter, topping the Zacks’ consensus estimate of $1.10 by $0.02. The business had revenue of $900.00 million during the quarter, compared to the consensus estimate of $886.85 million. CME Group had a net margin of 111.49% and a return on equity of 7.68%. The firm’s revenue was down 1.4% on a year-over-year basis. During the same period in the previous year, the company posted $1.14 earnings per share. analysts anticipate that CME Group will post 6.26 EPS for the current year.

In related news, insider Sunil Cutinho sold 2,600 shares of the stock in a transaction that occurred on Friday, November 17th. The shares were sold at an average price of $139.57, for a total value of $362,882.00. Following the transaction, the insider now owns 22,301 shares in the company, valued at approximately $3,112,550.57. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CFO John W. Pietrowicz sold 7,500 shares of the stock in a transaction that occurred on Tuesday, January 9th. The stock was sold at an average price of $151.50, for a total transaction of $1,136,250.00. Following the completion of the transaction, the chief financial officer now owns 32,376 shares in the company, valued at approximately $4,904,964. The disclosure for this sale can be found here. In the last quarter, insiders sold 39,828 shares of company stock worth $5,915,763. 0.57% of the stock is owned by corporate insiders.

Large investors have recently modified their holdings of the stock. Quadrant Capital Group LLC boosted its position in CME Group by 13.6% in the 2nd quarter. Quadrant Capital Group LLC now owns 944 shares of the financial services provider’s stock worth $111,000 after purchasing an additional 113 shares in the last quarter. Valeo Financial Advisors LLC purchased a new stake in CME Group in the 3rd quarter worth approximately $124,000. Bank of Nova Scotia Trust Co. purchased a new stake in CME Group in the 3rd quarter worth approximately $165,000. SeaCrest Wealth Management LLC purchased a new stake in CME Group in the 4th quarter worth approximately $203,000. Finally, LaFleur & Godfrey LLC purchased a new stake in CME Group in the 3rd quarter worth approximately $204,000. Institutional investors own 82.65% of the company’s stock.

TRADEMARK VIOLATION WARNING: This article was published by American Banking News and is owned by of American Banking News. If you are viewing this article on another domain, it was stolen and republished in violation of U.S. and international trademark & copyright law. The original version of this article can be viewed at https://www.americanbankingnews.com/2018/02/07/cme-group-cme-upgraded-at-goldman-sachs-group.html.

About CME Group

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

The Fly

Analyst Recommendations for CME Group (NASDAQ:CME)

Leave a Reply